Ziprasidone-induced hypersensitivity syndrome in an aged schizophrenia patient [2]

International Journal of Geriatric Psychiatry

Volumn 20, Issue 8, 2005, Pages 797-799

  Tsai, Chia Fen ^a   Tsai, Shih Jen ^a   Hwang, Jen Ping ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN E; LACTATE DEHYDROGENASE; OLANZAPINE; ZIPRASIDONE;

AGED; AGGRESSION; AUDITORY HALLUCINATION; BLOOD ANALYSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DELUSION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; JAUNDICE; LETTER; LIVER DYSFUNCTION; PARANOID SCHIZOPHRENIA;

AGED; ANTIPSYCHOTIC AGENTS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; PIPERAZINES; SCHIZOPHRENIA; THIAZOLES; TREATMENT OUTCOME;

EID: 23844443203     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.1346     Document Type: Letter

References (6)

1. Bonnetblanc JM. 1998. Drug hypersensitivity syndrome. Dermatology 187: 84-85.
2. Daniel DG. 2003. Tolerability of ziprasidone: an expanding perspective. J Clin Psychiatry 64(Suppl. 19): 40-49.
3. Knowles SR, Shapiro LE, Shear NH. 1999. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf 21: 489-501.
4. Raz A, Bergman R, Eilam O, Yungerman T, Hayek T. 2001. A case report of olanzapine-induced hypersensitivity syndrome. Am J Med Sci 321: 156-158.
5. Schlienger RG, Shear NH. 1998. Antiepileptic drug hypersensitivity syndrome. Epilepsia 39(Suppl. 7): S3-S7.
6. Verrotti A, Trotta D, Salladini C, Chiarelli F. 2002. Anticonvulsant hypersensitivity syndrome in children: incidence, prevention and management. CNS Drugs 16: 197-205.